Community-based Interventions to Increase HIV Testing and HIV Care Utilization

This study is not yet open for participant recruitment.
Verified May 2013 by Kaiser Permanente
Sponsor:
Collaborator:
University of California, San Diego
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01867177
First received: May 29, 2013
Last updated: May 31, 2013
Last verified: May 2013
  Purpose

The purpose of this study is to conduct a cross-site evaluation of the Kaiser Permanente's Community-based Interventions to Increase HIV Testing and HIV Care Utilization Program, designed to support community-based interventions to reduce the number of new HIV cases and to increase HIV care acquisition and maintenance in minority communities disproportionately affected by the HIV epidemic. This effort builds on the President's National Strategy for HIV Prevention and recent research documenting the importance and efficacy of "test and treat" and "treatment as prevention" approaches. Hence, goals of this important and novel work will focus on the following objectives:

  1. identification of HIV infection among recently infected adolescents and adults
  2. improved access to HIV care, particularly among newly diagnosed adolescents and adults

To achieve these objectives, the following outcomes are expected from grantee programs:

  1. increased HIV testing among populations at risk for HIV
  2. improved health care utilization among HIV infected adults and adolescents

This initiative has been undertaken by Kaiser to affect HIV at a population level via community approaches to prevention, intervention and care in minority communities most affected by HIV (e.g. gay, African American, and Latino communities). The University of California, San Diego has developed and will oversee a cross-site evaluation of Kaiser grantee programs funded under this initiative. Each site will have a treatment and comparison group, and will conduct follow up surveys with their participants three and six months after their interventions.


Condition Intervention
HIV
Other: HIV testing
Other: standard of HIV care
Behavioral: HIV care utilization

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Community-based Interventions to Increase HIV Testing and HIV Care Utilization

Resource links provided by NLM:


Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • Increased HIV care utilization [ Time Frame: 3 and 6 months following intervention ] [ Designated as safety issue: No ]
    Improved access to HIV care, particularly among newly diagnosed adults.


Secondary Outcome Measures:
  • Increased HIV testing among populations at risk for HIV [ Time Frame: at baseline ] [ Designated as safety issue: No ]
    Increased HIV testing among populations at risk for HIV and identification of HIV infection among recently infected adults.


Estimated Enrollment: 800
Study Start Date: June 2013
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
HIV testing
Identification of HIV infection among recently infected adults
Other: HIV testing
HIV testing. Enhanced testing protocol is used: RESPECT, an evidence-based HIV prevention counseling intervention helping people increase condom use, decrease risky behaviors (resulting in a decrease in STIs) compared to those who did not receive the intervention. RESPECT includes: one-on-one counseling using a structured protocol; "teachable moments" during counseling to motivate clients to change risk-taking behaviors; to explore the contexts in which risk behaviors occur to increase awareness of susceptibility; and negotiate achievable "next steps" with the client that support the larger risk reduction goal. Implemented using a structured protocol with monitoring to ensure the fidelity of the testing intervention.
Experimental: HIV care utilization
Improved access to HIV care and HIV care utilization, particularly among newly diagnosed adults
Behavioral: HIV care utilization
Sites will use a peer-based, client navigation model of an Integrated HIV/AIDS Early Intervention Services (ARTAS) Community Health Worker (CHW) Program (1-5 sessions with newly dx/dx within 12mo; case management/support services (4 contacts/mo/client for 6mo) linking people to continuous, coordinated care after HIV dx. Another site will do 3, 2hr Motivational Enhancement Intervention (MEI) sessions in 3 wks for HIV+: quality of life workshops, support groups at Butterfly Nest (safe project office for transgender women); 1 booster session (2hrs) after 3-month follow-up; 6mo follow-up assessment. Health Educators recruit clients, make appointments, escort to test sites, intake, review. 4th site will hold monthly risk-reduction workshops, weekly HIV testing for formerly incarcerated.
Active Comparator: standard of care
Standard of HIV care; standard of linkage to HIV care
Other: standard of HIV care
Standard linkage and referral to HIV care includes HIV counseling, testing, and referrals. Both intervention and comparison groups will receive these.

  Hide Detailed Description

Detailed Description:

This study is a cross-site evaluation of four projects in four states which all have two-armed study designs (intervention and comparison groups), whether quasi-experimental or Randomly controlled trials (RCTs) (depending on site preference). Therefore, some participants will be randomly sampled and others convenience sampled depending on the site.

Uniform surveys are approved by each sites' local Institutional Review Boards (IRBs). Trained site staff (not involved in the interventions) will administer the interview-led surveys to the participants, using computerized surveys for real-time data analysis and extra data security. Surveys will last approximately one hour, and will be administered in a private location in each site city (e.g. at the site agency) where confidentiality will be respected and where no one else can hear the interview. Survey measures include: Demographics; General health; Access and barriers to care; Health literacy; Non-partner related physical and sexual abuse history; Drug and alcohol use; HIV care and utilization and other utilization; HIV risk behaviors; HIV risk perceptions and condom attitudes; HIV stigma; Sexually transmitted infections and HCV2; Incarceration; Involvement with police; Social support; Intimate partner violence; Mental health; Impulsivity; Neighborhood violence and gang activity; Experiences of Racism; Sex and gender roles. The surveys will be administered at baseline, 3 months, and 6 months follow up.

Participants working illegally or conducting illegal practices such as illicit sex or working in establishments with illegal practices are not excluded from the study and will not be reported to the authorities by the researchers. If ethical issues should arise, such as danger to self or others, referrals will be made back to the site agencies and professional social work staff for appropriate intervention.

Each site will track participation and retention rates. In addition, site staff will do their own process evaluation, which will include the following: 1) Documenting recruitment and follow-up of participants (participation and retention rate data), 2) Documenting program delivery (program attendance data), 3) Monitoring high quality program delivery (program observations- quarterly reports; oversight/supervision of program quarterly reports), 4) Identifying impediments to high quality program delivery, planning to reduce or eliminate impediments (program coordinator notes- quarterly reports), 5) Assessing response to program from participants, staff, agencies (survey data; site level interview data may be useful as well). The local IRBs will review and approve the full procedure, including the intervention and evaluation plan at that site. The local staff will be hired by some sites after they are funded. They will do local training on the evaluation protocol and ethical conduct of research, as well as guidance by our UCSD evaluation staff.

Participants will vary by study site and no subjects will be enrolled in UCSD:

John Wesley Community Health (JWCH) Institute, Los Angeles, California. will recruit Black and Latino Men who have sex with Men, ages 18 and above from 3 bathhouses in downtown Los Angeles and near Long Beach. Of 4,000 who are tested, 140 are expected to be HIV-positive. These 140 will be randomly assigned to an Intervention group and control group. The program's outreach team will visit these venues in person to recruit participants and link them to an existing network of providers in the area.

Public Health Institute, Oakland, California. Total of 224 clients (Transgender Women of Color), will be served by Health Educators (HE) in Alameda and San Francisco Counties. 54 HIV+ enrolled (30 newly diagnosed, 24 known HIV cases); 170 HIV negatives. Outreach will be conducted through community outreach, online outreach via project website and social network sites, and networks of existing service providers.

Fortune Society, New York: 70 People Living with HIV/AIDS (PLWHA) about to be released from jail, plus 120 high-risk, formerly incarcerated individuals will be enrolled. Individuals are male and female, with the majority being African American and Latino. PLWHA will be reached by outreach staff during incarceration (detainees and inmates) in Rikers Island facilities and post-discharge; Fortune continues working with clients during discharge and upon their release into the community and 6 months post-discharge via Fortune's main service center in Queens, NY.

Institute for Public Health Innovation, Prince George's County, Maryland. 105 PLWA (HIV-positive African Americans, males and females, ages 18 and above) will be enrolled in a peer based, client navigation model of an Integrated HIV/AIDS Early Intervention Services (ARTAS) Community Health Worker (CHW) Program. The Institute will advertise services and conduct outreach to HIV-positive African Americans through clinical partners.

The purpose of the research will be discussed upfront with the subjects, in addition to revealing the sponsors of the research and how data will be reported. There will be no deception used in the survey. The consent forms will also explain the voluntary nature of the survey, the participant's right to withdraw from the interview at any time, and to opt out of questions they are not comfortable answering. The confidential nature of the data and identifying information as well as the limits to confidentiality (harm to self or another) will be explained as part of the consent process. Availability of the researcher to answer questions concerning the study at any time will be explained. Written informed consent will be waived, upon approval of this IRB, due to the sensitive nature of asking questions related to HIV testing and status. Verbal informed consent will be obtained instead and a copy of the consent form given to each participant. Participants will be given the option to reject or withdraw their participation in this survey research at any time. If they should not elect to participate in the protocol, alternatives available include referral to standard care services (such as regular workshops provided) and other community=based agencies.

There are minimal potential risks associated with participation in this study. However, participants may have an emotional reaction to discussing HIV-related issues and issues of a personal nature. If participation in this study makes a participant feel uncomfortable or if participants disclose information that requires further assistance by the law (child or elder abuse, or intent to harm oneself or another person), a psychologist or social work or medical professional may be contacted to meet with them to discuss their feelings and to determine if any assistance is necessary. If so, a list of potential referrals will be provided and a researcher will be in touch with them until assistance is found. Sites will vary in terms of whether cash or non-monetary incentives are given. Also, referrals to services/ resource lists and HIV prevention materials (e.g. condoms) will be provided by most sites.

The data safety monitoring plan for this study includes: 1) Data is transported to UCSD via a password-protected system 2) Only sites will have ID-identified data; the data we receive at UCSD would be completely de-identified. 3) Data submitted will only be submitted with de-identified data that is linked with identified data and contact information. 4) Sites will be asked to maintain notes for reasons of discontinuation in the study/program. They will be trained to review, and ultimately determine if there are patterns for heightened risk for study/program participants. 5) If for any reason we find adverse events as a result of the research studies (which we will check via quarterly progress reports), we will complete an adverse event form and immediately notify IRB and our funders. Computerized data files will only have unique identifying numbers (i.e. 10 digit id number), and names of participants will not be removed from the community study sites. Should participants wish to withdraw from the study, they can choose to have the data from both baseline and follow-up surveys removed from the study records and destroyed. Therapeutic treatment may be provided including referral to the community-based agency, social worker, or clinic/hospitals, as needed.

This study does not involve any investigational drugs or devices. The benefits outweigh the risks because this research only gathers survey data on behavioral outcomes. Also, interviews of participants in both intervention and comparison groups will help service providers monitor the needs of the target population more closely in case they need services or are experiencing barriers. The research can provide a feedback loop back to services if participants request them.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Individuals will be adults,
  • aged 18 and over,
  • with the capacity to give informed consent.

Exclusion Criteria:

Those who do not have the capacity to give informed consent will be excluded.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01867177

Contacts
Contact: Alexandra Caraballo 510-267-2888 Alexandra.X.Caraballo@kp.org
Contact: Anita Raj, PhD anitaraj@ucsd.edu

Locations
United States, California
University of California, San Diego, School of Medicine, Division of Global Public Health Not yet recruiting
La Jolla, California, United States, 92093
Principal Investigator: Anita Raj, PhD         
Sponsors and Collaborators
Kaiser Permanente
University of California, San Diego
Investigators
Principal Investigator: Anita Raj, PhD University of California, San Diego
  More Information

Publications:
Responsible Party: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT01867177     History of Changes
Other Study ID Numbers: KP2012
Study First Received: May 29, 2013
Last Updated: May 31, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
HIV
health care utilization
HIV testing
access to care

Additional relevant MeSH terms:
HIV Antibodies
Immunologic Factors
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 14, 2014